Renz H, et al. Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339. Differential expansion of V beta-expressing T cell populations. J. Immunol. Dec 1993; 151(12): 7206-7213.
Fukushima A, et al. Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr. Eye. Res. Aug 1998; 17(8): 763-769.
Oran, A. and H. Robinson, J. Immunol. 171, 1999 (2003)
OVA peptide 323-339 represents a T and B cell epitope of OVA, which is important in the generation and development of immediate hypersensitivity responses in BALB/c mice. Daily aerosolization of OVA 323-339 for 20 minutes over a period of 10 days has been as effective in the stimulation of a serum anti-OVA IgE antibody response as sensitization to native OVA by the same route. After sensitization to native OVA, the majority of the IgE anti-OVA response is directed against OVA peptide 323-339.
Solubility
Soluble in water
Formula
C74H120N26O25
M.W.
1772.94
Purity
95%
Storage
Store at -20°C.
* For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
